← FDA DRUG APPROVALS

FDA ANDA · ANDA078423

FLUCONAZOLE

Sponsor: ANI PHARMS

APPLICATION
ANDA078423
TYPE
ANDA
ORIGINAL APPROVAL
2011-03-07
LATEST ACTION
2025-01-29
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

FLUCONAZOLEPrescription
FLUCONAZOLE 200MG · TABLET · ORAL
FLUCONAZOLEPrescription
FLUCONAZOLE 100MG · TABLET · ORAL
FLUCONAZOLEPrescription
FLUCONAZOLE 150MG · TABLET · ORAL
FLUCONAZOLEPrescription
FLUCONAZOLE 50MG · TABLET · ORAL

Approval history

2025-01-29Labeling · Supplement 27 · standardAP
2025-01-29Labeling · Supplement 31 · standardAP
2021-04-27Labeling · Supplement 13 · standardAP
2021-04-27Labeling · Supplement 9 · standardAP
2021-04-27Labeling · Supplement 12 · standardAP
2017-03-10Manufacturing (CMC) · Supplement 7 · unknownAP
2015-03-14Labeling · Supplement 2 · standardAP
2015-03-14Labeling · Supplement 1 · standardAP
2011-03-07OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →